Is Nuvation Bio Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 4 Wall Street analysts covering (NYSE: NUVB) stock is to Strong Buy NUVB stock.
Out of 4 analysts, 2 (50%) are recommending NUVB as a Strong Buy, 2 (50%) are recommending NUVB as a Buy, 0 (0%) are recommending NUVB as a Hold, 0 (0%) are recommending NUVB as a Sell, and 0 (0%) are recommending NUVB as a Strong Sell.
What is NUVB's forecast return on equity (ROE) for 2024-2027?
(NYSE: NUVB) forecast ROE is N/A, which is considered weak.
What is NUVB's Price Target?
According to 4 Wall Street analysts that have issued a 1 year NUVB price target, the average NUVB price target is $6.25, with the highest NUVB stock price forecast at $10.00 and the lowest NUVB stock price forecast at $5.00.
On average, Wall Street analysts predict that Nuvation Bio's share price could reach $6.25 by Mar 27, 2025. The average Nuvation Bio stock price prediction forecasts a potential upside of 57.43% from the current NUVB share price of $3.97.
What is NUVB's forecast return on assets (ROA) for 2024-2027?
(NYSE: NUVB) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.